Xu Chen

10.3k total citations · 2 hit papers
277 papers, 6.9k citations indexed

About

Xu Chen is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xu Chen has authored 277 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Molecular Biology, 59 papers in Cancer Research and 52 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xu Chen's work include Cancer-related molecular mechanisms research (29 papers), RNA modifications and cancer (28 papers) and MicroRNA in disease regulation (24 papers). Xu Chen is often cited by papers focused on Cancer-related molecular mechanisms research (29 papers), RNA modifications and cancer (28 papers) and MicroRNA in disease regulation (24 papers). Xu Chen collaborates with scholars based in China, United States and Hong Kong. Xu Chen's co-authors include Tianxin Lin, Jian Huang, Ruihui Xie, Ming Huang, Wen Dong, Wang He, Guangzheng Zhong, Jinli Han, Ziyue Chen and Weibin Xie and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Xu Chen

254 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer

2023 128 citations Ruihui Xie, Liang Cheng et al. Cancer Research profile →
Stem cells vesicles-loaded type I pro-photosensitizer for synergetic oxygen-independent phototheranostics and microenvironment regulation in infected diabetic wounds

2025 17 citations Qin Zeng, Ying Zhang et al. Chemical Engineering Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xu Chen China	48	3.9k	2.0k	1.2k	965	886	277	6.9k
Xin Jin China	42	3.8k 1.0×	1.5k 0.7×	1.4k 1.2×	528 0.5×	922 1.0×	295	6.4k
Hao Liu China	44	3.2k 0.8×	1.9k 1.0×	1.5k 1.3×	929 1.0×	941 1.1×	321	7.0k
Jian Wu China	46	4.1k 1.1×	2.7k 1.3×	871 0.8×	786 0.8×	648 0.7×	206	6.9k
Lu Zhang China	47	6.0k 1.5×	2.8k 1.4×	1.2k 1.1×	678 0.7×	651 0.7×	383	9.5k
Haiyan Li China	40	2.7k 0.7×	1.3k 0.6×	1.2k 1.0×	618 0.6×	715 0.8×	270	5.8k
Min Shi China	39	3.5k 0.9×	2.1k 1.0×	1.6k 1.4×	620 0.6×	1.6k 1.9×	164	6.7k
Li‐Yan Xu China	44	4.5k 1.2×	2.0k 1.0×	1.4k 1.2×	984 1.0×	1.0k 1.2×	367	7.5k
Jingwen Zhang China	45	3.4k 0.9×	1.2k 0.6×	1.4k 1.2×	774 0.8×	985 1.1×	296	7.7k
Yiping Wang China	47	3.8k 1.0×	1.8k 0.9×	740 0.6×	565 0.6×	630 0.7×	215	7.5k
Shi Chen China	39	2.4k 0.6×	1.0k 0.5×	1.1k 0.9×	862 0.9×	920 1.0×	291	6.0k

Countries citing papers authored by Xu Chen

Since Specialization

Citations

This map shows the geographic impact of Xu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Chen more than expected).

Fields of papers citing papers by Xu Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Chen. The network helps show where Xu Chen may publish in the future.

Co-authorship network of co-authors of Xu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Chen. A scholar is included among the top collaborators of Xu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Chen. Xu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Peng, Xu Chen, Yi Qin, et al.. (2025). Regulation of osteoimmune microenvironment via functional dynamic hydrogel for diabetic bone regeneration. Biomaterials. 320. 123273–123273. 3 indexed citations

Lin, Yunfan, Pei Lin, Xu Chen, et al.. (2025). Nanovaccines empowering CD8⁺ T cells: a precision strategy to enhance cancer immunotherapy. Theranostics. 15(7). 3098–3121. 7 indexed citations

Zeng, Qin, Ying Zhang, Judun Zheng, et al.. (2025). Stem cells vesicles-loaded type I pro-photosensitizer for synergetic oxygen-independent phototheranostics and microenvironment regulation in infected diabetic wounds. Chemical Engineering Journal. 505. 159239–159239. 17 indexed citations breakdown →

Zhan, Hengji, Bailin Pan, Junlin Lu, et al.. (2025). Reprogramming the tumor microenvironment with c-MYC-based gene circuit platform to enhance specific cancer immunotherapy. Nature Communications. 16(1). 7983–7983. 1 indexed citations

Li, Ying, Xu Chen, Jinhong Li, et al.. (2024). DNA adductomics aided rapid screening of genotoxic impurities using nucleosides and 3D bioprinted human liver organoids. Talanta. 273. 125902–125902. 9 indexed citations

Luo, Rongkui, Wen Huang, Wei Yuan, et al.. (2024). IKZF3 amplification predicts worse prognosis especially in intestinal-type gastric cancer. Journal of Cancer Research and Clinical Oncology. 150(7). 363–363. 1 indexed citations

Cheng, Liang, Junlin Lu, Ming Huang, et al.. (2024). Oncogenic SLC2A11–MIF fusion protein interacts with polypyrimidine tract binding protein 1 to facilitate bladder cancer proliferation and metastasis by regulating mRNA stability. SHILAP Revista de lepidopterología. 5(9). e685–e685. 8 indexed citations

Zhang, Ruijuan, Xu Chen, Yuxuan Chen, et al.. (2023). Tumor-associated macrophage-derived exosomal miR-513b-5p is a target of jianpi yangzheng decoction for inhibiting gastric cancer. Journal of Ethnopharmacology. 318(Pt B). 117013–117013. 11 indexed citations

Wang, Jinhua, Jiajing Cai, Yilin Shen, et al.. (2023). Post-Traumatic Stress Disorder Is Associated with Elevated Plasma Cholesterol in Female TT Homozygotes of LDLR rs5925. International Journal of Molecular Sciences. 24(10). 9016–9016.

10.

Zheng, Junjiong, Sihong Lu, Yi Huang, et al.. (2023). Preoperative fluorescence in situ hybridization analysis as a predictor of tumor recurrence in patients with non-muscle invasive bladder cancer: a bi-institutional study. Journal of Translational Medicine. 21(1). 685–685. 2 indexed citations

11.

Tang, Chao, Dan Chen, Xu Chen, et al.. (2023). Natural polysaccharides protect against diet-induced obesity by improving lipid metabolism and regulating the immune system. Food Research International. 172. 113192–113192. 45 indexed citations

12.

Zhu, Wenjie, et al.. (2022). Low Glucose–Induced Overexpression of HOXC-AS3 Promotes Metabolic Reprogramming of Breast Cancer. Cancer Research. 82(5). 805–818. 25 indexed citations

13.

Huang, Ming, Wen Dong, Ruihui Xie, et al.. (2022). HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program. Cancer Communications. 42(5). 447–470. 76 indexed citations

14.

Gong, Wei, Jiancheng Xu, Yan Wang, et al.. (2022). Nuclear genome-derived circular RNA circPUM1 localizes in mitochondria and regulates oxidative phosphorylation in esophageal squamous cell carcinoma. Signal Transduction and Targeted Therapy. 7(1). 40–40. 83 indexed citations

15.

Lu, Theresa T., Liankun Sun, Zhiqiang Wang, et al.. (2019). Fatty acid synthase enhances colorectal cancer cell proliferation and metastasis via regulating AMPK/mTOR pathway. SHILAP Revista de lepidopterología. 1 indexed citations

16.

Zhang, Qi, Xu Chen, Jing Pan, et al.. (2019). Optimized Bexarotene Aerosol Formulation Inhibits Major Subtypes of Lung Cancer in Mice. Nano Letters. 19(4). 2231–2242. 15 indexed citations

17.

Chen, Xu, Ruihui Xie, Peng Gu, et al.. (2018). Long Noncoding RNA LBCS Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2. Clinical Cancer Research. 25(4). 1389–1403. 180 indexed citations

18.

Chen, Xu, et al.. (2016). Paxillin functions as an oncogene in human gliomas by promoting cell migration and invasion. SHILAP Revista de lepidopterología. 1 indexed citations

19.

Chen, Xu, Michelle M. Thiaville, Li Chen, et al.. (2012). Defining NOTCH3 Target Genes in Ovarian Cancer. Cancer Research. 72(9). 2294–2303. 56 indexed citations

20.

Kuo, Kuan‐Ting, Bin Guan, Yuanjian Feng, et al.. (2009). Analysis of DNA Copy Number Alterations in Ovarian Serous Tumors Identifies New Molecular Genetic Changes in Low-Grade and High-Grade Carcinomas. Cancer Research. 69(9). 4036–4042. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact